| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

( McArdle Memorial Laboratory, Medical School, University of Wisconsin, Madison, Wis.)
* This was supported in part by grants from the Alexander and Margaret Stewart Trust Fund and from the American Cancer Society.
A preliminary report of this work was presented at the Annual Meeting of the American Association for Cancer Research, April, 1958.
American-British Exchange Fellow in Cancer Research, supported by the British Empire Cancer Campaign and the American Cancer Society.
This article has been cited by other articles:
![]() |
S. R. Ostrowski, S. Wilbur, C.-H. S. J. Chou, H. R. Pohl, Y.-W. Stevens, P. M. Allred, N. Roney, M. Fay, and C. A. Tylenda Agency for Toxic Substances and Disease Registry's 1997 priority list of hazardous substances. Latent effects--carcinogenesis, neurotoxicology, and developmental deficits in humans and animals Toxicology and Industrial Health, August 1, 1999; 15(7): 602 - 644. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |